ArticleOncotarget2018

Octogenarians with EGFR-mutated non-small cell lung cancer treated by tyrosine-kinase inhibitor: a multicentric real-world study assessing tolerance and efficacy (OCTOMUT study).

Romain Corre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.